Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**ENSG00000226141** refers to a human *pseudogene* related to the **sodium- and chloride-dependent creatine transporter** family, specifically named "solute carrier family 6 member 10, pseudogene" or SLC6A10P[7][8]. Pseudogenes are non-functional gene copies that do not encode active proteins; SLC6A10P shares homology with the functional creatine transporter gene SLC6A8 but does not produce a functional transporter. It has no established biological function, disease involvement, or therapeutic relevance, and is not considered a drug target[7][8][4].\n\n**Additional context:** \n- The canonical, therapeutically actionable creatine transporter is **sodium- and chloride-dependent creatine transporter 1 (SLC6A8)**, which is functional and clinically relevant in creatine transporter deficiency syndromes[1][2][9][10]. \n- ENSG00000226141 and its encoded pseudogene (SLC6A10P) are distinct from SLC6A8 and do not encode a transporter protein[7][8].\n- Pseudogenes may sometimes have regulatory effects on their parental gene but SLC6A10P has no characterized biological function or disease relevance in current literature[8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Similar to sodium- and chloride-dependent creatine transporter pseudogene.